|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Lucid Diagnostics (NASDAQ: LUCD) through any online brokerage.
The latest price target for Lucid Diagnostics (NASDAQ: LUCD) was reported by BTIG on November 8, 2021. The analyst firm set a price target for 14.00 expecting LUCD to rise to within 12 months (a possible 94.71% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $7.19 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Lucid Diagnostics.
Lucid Diagnostics’s $Q4 earnings are confirmed for after-market on February 16, 2022.
There is no upcoming split for Lucid Diagnostics.
Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.